New patent for Biocryst drug ORLADEYO

   May 6, 2023    Comments Off on New patent for Biocryst drug ORLADEYO    Posted in: Patent Added

Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are six patents protecting…

The post New patent for Biocryst drug ORLADEYO appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog